Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Quarterly results
TETRAPHASE PHARMACEUTICALS INC (TTPH) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/31/2020 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
08/31/2020 EFFECT Form EFFECT - Notice of Effectiveness:
08/31/2020 EFFECT Form EFFECT - Notice of Effectiveness:
08/31/2020 EFFECT Form EFFECT - Notice of Effectiveness:
08/24/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/24/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/24/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/24/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/24/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/24/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/24/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/24/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/24/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/24/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
08/24/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
08/24/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
08/24/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
08/24/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
07/30/2020 SC 13D/A ARMISTICE CAPITAL, LLC reports a 0% stake in Tetraphase Pharmaceuticals, Inc.
07/29/2020 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/29/2020 8-K Quarterly results
07/28/2020 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
07/28/2020 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
07/28/2020 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
07/28/2020 GN La Jolla Pharmaceutical Company Announces the Closing of Acquisition of Tetraphase Pharmaceuticals, Inc.
07/20/2020 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
06/30/2020 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
06/30/2020 SC 13D/A ARMISTICE CAPITAL, LLC reports a 20% stake in Tetraphase Pharmaceuticals, Inc.
06/29/2020 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
06/29/2020 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
06/25/2020 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
06/24/2020 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
06/24/2020 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
06/24/2020 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy